As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
On March 18, Medicilon and Korea Pharmaceutical Manufacturers Association (KPMA) held a CFDA IND seminar in Seoul, South Korea. The theme of this seminar is “Experience Sharing and Exchange on CFDA’s IND Application and Drug Development Collaboration”. About 130 medical experts and scientists from more than 50 companies participated in this seminar. Medicilon CEO Dr. Chunlin Chen shared his CFDA IND application experience with Korean customers. Dr. Chen clearly explained the IND application process in China. The experts from South Korea showed strong interest in Medicilon’s IND service and further discussed the possibility of cooperation with Medicilon.
Relevant
news
marketing@medicilon.com
ABOUT
